Synapse Open Synapse
Biology

The next big shake-up in the GLP-1 market? (Part 1 of 3)

Labiotech.eu · · 1 min read

In part one of our series, I’m joined by Valeriia Simanovskaia, founder and CEO of BioBrokers, an independent capital markets and strategic advisory firm for life sciences.

Latest from Labiotech.eu